Literature DB >> 26797962

The Role and Immunobiology of Eosinophils in the Respiratory System: a Comprehensive Review.

Stephanie S Eng1,2, Magee L DeFelice3,4.   

Abstract

The eosinophil is a fully delineated granulocyte that disseminates throughout the bloodstream to end-organs after complete maturation in the bone marrow. While the presence of eosinophils is not uncommon even in healthy individuals, these granulocytes play a central role in inflammation and allergic processes. Normally appearing in smaller numbers, higher levels of eosinophils in the peripheral blood or certain tissues typically signal a pathologic process. Eosinophils confer a beneficial effect on the host by enhancing immunity against molds and viruses. However, tissue-specific elevation of eosinophils, particularly in the respiratory system, can cause a variety of short-term symptoms and may lead to long-term sequelae. Eosinophils often play a role in more commonly encountered disease processes, such as asthma and allergic responses in the upper respiratory tract. They are also integral in the pathology of less common diseases including eosinophilic pneumonia, allergic bronchopulmonary aspergillosis, hypersensitivity pneumonitis, and drug reaction with eosinophilia and systemic symptoms. They can be seen in neoplastic disorders or occupational exposures as well. The involvement of eosinophils in pulmonary disease processes can affect the method of diagnosis and the selection of treatment modalities. By analyzing the complex interaction between the eosinophil and its environment, which includes signaling molecules and tissues, different therapies have been discovered and created in order to target disease processes at a cellular level. Innovative treatments such as mepolizumab and benralizumab will be discussed. The purpose of this article is to further explore the topic of eosinophilic presence, activity, and pathology in the respiratory tract, as well as discuss current and future treatment options through a detailed literature review.

Entities:  

Keywords:  Acute eosinophilic pneumonia; Allergic bronchopulmonary aspergillosis; Asthma endotype; Asthma phenotype; Chronic eosinophilic pneumonia; Eosinophil; Eosinophilia; Extrinsic asthma; Intrinsic asthma; Respiratory system; Severe Asthma

Mesh:

Year:  2016        PMID: 26797962     DOI: 10.1007/s12016-015-8526-3

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  150 in total

Review 1.  A global perspective in asthma: from phenotype to endotype.

Authors:  Min Xie; Sally E Wenzel
Journal:  Chin Med J (Engl)       Date:  2013-01       Impact factor: 2.628

2.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

Review 3.  Acute lymphocytic leukemia with eosinophilia: two case reports and a literature review.

Authors:  Floranne Wilson; Ayalew Tefferi
Journal:  Leuk Lymphoma       Date:  2005-07

Review 4.  Eosinophilic pneumonias.

Authors:  V Cottin; J-F Cordier
Journal:  Allergy       Date:  2005-07       Impact factor: 13.146

Review 5.  Pathogenesis and disease mechanisms of occupational asthma.

Authors:  Zana L Lummus; Adam V Wisnewski; David I Bernstein
Journal:  Immunol Allergy Clin North Am       Date:  2011-11       Impact factor: 3.479

6.  Treatment of steroid-dependent bronchial asthma with cyclosporin.

Authors:  E Nizankowska; J Soja; G Pinis; G Bochenek; K Sładek; B Domagała; A Pajak; A Szczeklik
Journal:  Eur Respir J       Date:  1995-07       Impact factor: 16.671

Review 7.  Eosinophils in the pathogenesis of allergic airways disease.

Authors:  S G Trivedi; C M Lloyd
Journal:  Cell Mol Life Sci       Date:  2007-05       Impact factor: 9.261

Review 8.  Acute eosinophilic pneumonia: A case report and review of the literature.

Authors:  David R Janz; Hollis R O'Neal; E Wesley Ely
Journal:  Crit Care Med       Date:  2009-04       Impact factor: 7.598

Review 9.  Diagnosis and management of eosinophilic asthma: a US perspective.

Authors:  Hannah H Walford; Taylor A Doherty
Journal:  J Asthma Allergy       Date:  2014-04-11

10.  Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.

Authors:  Elisabeth H Bel; Sally E Wenzel; Philip J Thompson; Charlene M Prazma; Oliver N Keene; Steven W Yancey; Hector G Ortega; Ian D Pavord
Journal:  N Engl J Med       Date:  2014-09-08       Impact factor: 91.245

View more
  11 in total

Review 1.  The Inflammasome and Type-2 Immunity in Clostridium difficile Infection.

Authors:  Alexandra Donlan; William A Petri
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

Review 2.  IL-6 modulation for COVID-19: the right patients at the right time?

Authors:  Paolo Antonio Ascierto; Binqing Fu; Haiming Wei
Journal:  J Immunother Cancer       Date:  2021-04       Impact factor: 12.469

Review 3.  Regulation of Eosinophil Recruitment and Activation by Galectins in Allergic Asthma.

Authors:  Savita P Rao; Xiao Na Ge; P Sriramarao
Journal:  Front Med (Lausanne)       Date:  2017-05-31

4.  Deguelin Attenuates Allergic Airway Inflammation via Inhibition of NF-κb Pathway in Mice.

Authors:  Zhang Bao; Pei Zhang; Yinan Yao; Guohua Lu; Zhongkai Tong; Bing Yan; Lingfang Tu; Guangdie Yang; Jianying Zhou
Journal:  Int J Biol Sci       Date:  2017-04-08       Impact factor: 6.580

5.  A Pitfall in the Diagnosis of Eosinophilic Myocarditis in a Patient who Received Steroid Therapy.

Authors:  Yusuke Watanabe; Hiroshi Wada; Kenichi Sakakura; Hideo Fujita; Shin-Ichi Momomura
Journal:  Intern Med       Date:  2017-01-15       Impact factor: 1.271

Review 6.  Exosomes: A Key Piece in Asthmatic Inflammation.

Authors:  José A Cañas; José M Rodrigo-Muñoz; Marta Gil-Martínez; Beatriz Sastre; Victoria del Pozo
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

7.  Predictive Value of Eosinophil Count on COVID-19 Disease Progression and Outcomes, a Retrospective Study of Leishenshan Hospital in Wuhan, China.

Authors:  Wei Xuan; Xuliang Jiang; Lili Huang; Shuting Pan; Caiyang Chen; Xiao Zhang; Hui Zhu; Song Zhang; Weifeng Yu; Zhiyong Peng; Diansan Su
Journal:  J Intensive Care Med       Date:  2021-09-22       Impact factor: 3.510

8.  Eosinophil as a biomarker for diagnosis, prediction, and prognosis evaluation of severe checkpoint inhibitor pneumonitis.

Authors:  Yanlin Li; Xiaohui Jia; Yonghao Du; Ziyang Mao; Yajuan Zhang; Yuan Shen; Hong Sun; Mengjie Liu; Gang Niu; Jun Wang; Jie Hu; Min Jiao; Hui Guo
Journal:  Front Oncol       Date:  2022-08-12       Impact factor: 5.738

9.  Tomatidine Attenuates Airway Hyperresponsiveness and Inflammation by Suppressing Th2 Cytokines in a Mouse Model of Asthma.

Authors:  Chieh-Ying Kuo; Wen-Chung Huang; Chian-Jiun Liou; Li-Chen Chen; Jiann-Jong Shen; Ming-Ling Kuo
Journal:  Mediators Inflamm       Date:  2017-11-21       Impact factor: 4.711

Review 10.  A Pathophysiological Perspective on COVID-19's Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation.

Authors:  Marcos A Sanchez-Gonzalez; Dave Moskowitz; Priya D Issuree; George Yatzkan; Syed A A Rizvi; Kenneth Day
Journal:  Infect Chemother       Date:  2020-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.